
Yung Lyou, MD, PhD, discusses the key takeaways from the phase 3 ENZAMET trial in metastatic prostate cancer.

Your AI-Trained Oncology Knowledge Connection!


Yung Lyou, MD, PhD, discusses the key takeaways from the phase 3 ENZAMET trial in metastatic prostate cancer.

Yung Lyou, MD, PhD, discusses the efficacy of androgen-deprivation therapy plus docetaxel in patients with metastatic hormone-sensitive prostate cancer.

Yung Lyou, MD, PhD, discusses emerging biomarkers in prostate cancer.

Yung Lyou, MD, PhD, discusses optimal sequencing with apalutamide in prostate cancer.

Published: August 30th 2021 | Updated:

Published: July 16th 2021 | Updated:

Published: August 31st 2021 | Updated:

Published: July 19th 2021 | Updated: